|

AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

RECRUITINGSponsored by Grand Hôpital de Charleroi
Actively Recruiting
SponsorGrand Hôpital de Charleroi
Started2026-02-15
Est. completion2027-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07546188

Summary

This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients aged 18 and over who are treated in the Haematology Department at the Grand Hôpital de Charleroi from November 2025 onwards
* Treated for a lymphoma, Non Hodgkin
* Capable of giving informed consent

Exclusion Criteria:

* All other patients who did not meet the eligibility criteria

Conditions3

CancerCare CoordinationLymphoma, Non-Hodgkin

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.